1. Home
  2. ARDX vs EVER Comparison

ARDX vs EVER Comparison

Compare ARDX & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • EVER
  • Stock Information
  • Founded
  • ARDX 2007
  • EVER 2008
  • Country
  • ARDX United States
  • EVER United States
  • Employees
  • ARDX N/A
  • EVER N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • EVER Computer Software: Programming Data Processing
  • Sector
  • ARDX Health Care
  • EVER Technology
  • Exchange
  • ARDX Nasdaq
  • EVER Nasdaq
  • Market Cap
  • ARDX 882.9M
  • EVER 929.6M
  • IPO Year
  • ARDX 2014
  • EVER 2018
  • Fundamental
  • Price
  • ARDX $6.52
  • EVER $23.54
  • Analyst Decision
  • ARDX Strong Buy
  • EVER Strong Buy
  • Analyst Count
  • ARDX 9
  • EVER 5
  • Target Price
  • ARDX $10.50
  • EVER $32.40
  • AVG Volume (30 Days)
  • ARDX 3.5M
  • EVER 478.9K
  • Earning Date
  • ARDX 10-30-2025
  • EVER 11-03-2025
  • Dividend Yield
  • ARDX N/A
  • EVER N/A
  • EPS Growth
  • ARDX N/A
  • EVER N/A
  • EPS
  • ARDX N/A
  • EVER 1.24
  • Revenue
  • ARDX $386,146,000.00
  • EVER $615,246,000.00
  • Revenue This Year
  • ARDX $16.83
  • EVER $32.27
  • Revenue Next Year
  • ARDX $28.55
  • EVER $11.05
  • P/E Ratio
  • ARDX N/A
  • EVER $19.12
  • Revenue Growth
  • ARDX 83.88
  • EVER 92.92
  • 52 Week Low
  • ARDX $3.21
  • EVER $16.63
  • 52 Week High
  • ARDX $7.18
  • EVER $30.03
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 79.80
  • EVER 48.74
  • Support Level
  • ARDX $6.38
  • EVER $22.64
  • Resistance Level
  • ARDX $6.65
  • EVER $23.88
  • Average True Range (ATR)
  • ARDX 0.22
  • EVER 0.71
  • MACD
  • ARDX 0.00
  • EVER 0.08
  • Stochastic Oscillator
  • ARDX 85.53
  • EVER 62.73

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

Share on Social Networks: